SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MERIGHI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.869
EU - Europa 4.228
AS - Asia 3.250
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 7
AF - Africa 3
Totale 21.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.812
CN - Cina 1.580
UA - Ucraina 961
DE - Germania 940
SG - Singapore 811
IT - Italia 780
TR - Turchia 683
GB - Regno Unito 423
SE - Svezia 333
FI - Finlandia 276
PL - Polonia 155
RU - Federazione Russa 121
FR - Francia 72
ID - Indonesia 60
CA - Canada 52
HK - Hong Kong 52
BE - Belgio 47
NL - Olanda 27
LT - Lituania 25
CZ - Repubblica Ceca 19
ES - Italia 18
VN - Vietnam 13
IN - India 11
JP - Giappone 8
AU - Australia 7
IR - Iran 7
EU - Europa 6
AT - Austria 5
IL - Israele 5
KR - Corea 5
MX - Messico 5
CL - Cile 4
CH - Svizzera 3
HU - Ungheria 3
MY - Malesia 3
NO - Norvegia 3
RO - Romania 3
TW - Taiwan 3
BD - Bangladesh 2
BG - Bulgaria 2
DZ - Algeria 2
GR - Grecia 2
IE - Irlanda 2
IM - Isola di Man 2
IQ - Iraq 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 21.372
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.755
Fairfield 1.554
Jacksonville 1.091
Chandler 1.076
Houston 1.036
Ann Arbor 878
Ashburn 775
Santa Clara 765
Singapore 656
Seattle 649
Wilmington 639
Cambridge 532
Izmir 364
Nanjing 335
Beijing 295
Ferrara 273
Princeton 255
Boardman 197
Milan 192
Warsaw 154
Shanghai 139
Dearborn 126
San Diego 115
Shenyang 110
Nanchang 105
Los Angeles 100
Addison 90
Bremen 82
New York 74
Helsinki 68
Hebei 64
Tianjin 64
Changsha 61
Jakarta 60
Hong Kong 49
Brussels 45
Jiaxing 45
San Mateo 43
Jinan 42
London 42
Falls Church 39
Mountain View 35
Kunming 34
Norwalk 32
Zhengzhou 31
Toronto 28
Auburn Hills 26
Redwood City 25
Munich 24
Ningbo 24
Frankfurt am Main 23
Philadelphia 23
Chicago 20
Des Moines 20
Guangzhou 20
Orange 19
Lanzhou 16
Verona 16
Bologna 14
Falkenstein 14
Ottawa 14
Tappahannock 14
Hefei 13
Washington 13
Dong Ket 12
Ferrara di Monte Baldo 12
Hangzhou 12
Redmond 12
Taizhou 12
Brno 11
Indiana 10
Nice 10
Meppel 9
Otura 9
Rome 9
Haikou 8
Augusta 7
Düsseldorf 7
Florence 7
Reggio Emilia 7
Edinburgh 6
Hounslow 6
Kilburn 6
Padova 6
Genoa 5
Las Vegas 5
Venice 5
Amsterdam 4
Ardabil 4
Espoo 4
Montreal 4
New Bedfont 4
Olomouc 4
Pune 4
San Francisco 4
Tel Aviv 4
Adelaide 3
Bari 3
Budapest 3
Calderara Di Reno 3
Totale 15.773
Salva come PNG Salva come JPEG
Nome #
A glance at adenosine receptors: Novel target for antitumor therapy 202
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 201
Pharmacology of Adenosine Receptors: The State of the Art 169
The A3 adenosine receptor: history and perspectives 167
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 166
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 162
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 160
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 157
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 155
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 153
Adenosine receptors and human melanoma 146
Pathological overproduction: the bad side of adenosine 146
Adenosine receptor targeting in health and disease 145
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 141
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 140
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 139
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 138
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 137
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 134
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 133
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 131
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 131
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 131
Adenosine receptors and cancer 129
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 129
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 128
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 127
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 126
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 125
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 125
null 125
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 124
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 123
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 123
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 123
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 122
New potent and selective human adenosine A3 receptor antagonists. 122
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 119
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 119
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 119
Adenosine and lymphocyte regulation 119
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 118
A(2A) adenosine receptors in human peripheral blood cells 118
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 118
null 118
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 118
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 117
Agonists and antagonists: Molecular mechanisms and therapeutic applications 117
The A3 adenosine receptor: an enigmatic player in cell biology. 116
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 116
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 116
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 115
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 115
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 114
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 114
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 114
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 114
null 113
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 113
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 113
null 112
Adenosine receptors in health and disease 112
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 111
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 110
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 110
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 110
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 110
Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors 109
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 109
van't Hoff Based Thermodynamics 109
Adenosine A2A receptors in human circulating blood elements 108
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 108
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 108
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 108
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 108
null 107
PKCε as a novel promoter of skeletal muscle differentiation and regeneration 107
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 107
null 106
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 105
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 105
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells 105
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A(3) adenosine receptors 104
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 104
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 103
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 102
null 102
null 102
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 101
New potent and selective human adenosine A3 receptor antagonists 101
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 99
Targeting A3 and A2A adenosine receptors in the fight against cancer 99
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 98
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 98
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 97
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 97
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 97
Glucocorticoids' pharmacology: Past, present and future 97
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 96
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 96
Totale 12.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.990
Totale 102.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.310 0 0 0 0 0 494 379 417 319 433 207 61
2020/20213.065 281 309 129 367 149 325 118 343 64 454 369 157
2021/20222.157 45 228 152 75 84 97 81 104 76 183 322 710
2022/20232.535 245 223 91 337 424 325 140 203 291 24 143 89
2023/20241.272 113 168 44 27 131 139 53 93 32 54 65 353
2024/20252.248 128 192 419 289 701 519 0 0 0 0 0 0
Totale 21.681